Videos

Edward J. Septimus, MD, explains how smaller hospitals can overcome the challenges that come with having fewer resources to implement a robust antibiotic stewardship program.

Jason M. Pogue, PharmD, discusses the challenges clinicians face when dosing beta-lactams based on the current guidelines.

Nathan A. Everson, PharmD, AAHIVE, shares some hidden challenges clinicians should address when implementing antibiotic stewardship interventions in the outpatient setting.

Bruce A. Mueller, PharmD, shares how clinicians in the inpatient setting can quantify acute kidney injury in adults on antibiotics.

Joseph Eron, MD, explains how integrase inhibitors have dramatically changed HIV therapy for the better.

Julia E. Szymczak, PhD, shares the results of her study which revealed that fear drives some clinicians to prescribe inappropriately.

Colleen Kelley, MD, describes the role of health care providers in linking patients with PrEP.

Mike Kohut, PhD shares the results of his research that reveals providers are writing prescriptions for infections based largely on patient demand and not guideline recommendations.

Emil Lesho, DO, FACP, FIDSA, FSHEA, explains what makes Elizabethkingia unique.

Joseph Eron, MD, discusses benefits of long-acting injectable antiretroviral therapy as well as misconceptions.

Barley Chironda, RPN, CIC, explains the role that nurses play in disinfection practices at health care facilities.

Marin H. Kollef, MD, discusses new therapies in development for the treatment of Pseudomonas infections.

Joseph Eron, MD, explains how some individuals acquire resistance to HIV therapy and discusses new drugs in the pipeline that are effective against resistant virus.

Colleen Kelley, MD, stresses the importance of routinizing HIV testing and shares what physicians can do if their patient declines the option to get tested.

Debra Goff, PharmD, FCCP, explains how mobile apps are being used by health care providers to improve patient outcomes.

Barley Chironda, RPN, CIC, infection control specialist at Clorox Healthcare, explains how cell phones and smart devices can potentially serve as a vector for C. diff.

Joseph Eron, MD, discusses when clinicians may expect to have access to long-acting injectable ART and the different opportunities it offers for individuals with HIV.

Colleen Kelley, MD, explains what is needed to ensure that individuals get tested for HIV.

Marin H. Kollef, MD, discusses the strongest approach for treating Pseudomonas infections.

Barley Chironda, RPN, CIC, explains why current environmental disinfection practices aren’t making the cut.

Debra Goff, PharmD, FCCP, discusses how the STAB-IT app helps health care providers with real-time point-of-care management of Staphylococcus aureus bacteremia.

Experts in the field of HIV provide their key takeaways from CROI 2018.

Jonathan Colasanti, MD, MSPH, shares how the introduction of a Rapid Entry Program in Atlanta proved successful at improving access to HIV care and viral suppression rates.

Dr. Richard Vickers, discusses C. difficile rates in the United Kingdom.

Debra Goff, PharmD, FCCP, explains how technology can be incorporated into antimicrobial stewardship programs.

Barley Chironda, RPN, CIC, discusses different high-touch surfaces in hospital rooms that are known to harbor pathogenic bacteria.

Marin H. Kollef, MD, discusses treatment options for Pseudomonas aeruginosa.

Glenn Tillotson, PhD, FIDSA, provides insight into the growing problem and cost of antimicrobial resistance.